从容器植入物中持续释放RNA纳米颗粒用于眼部输送
Zhanquan Shi1, Cheng Zhong1, Daniel W Binzel2
1Division of Pharmaceutical Sciences, College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267, United States.
Journal of pharmaceutical sciences
|December 26, 2024
概括
环膜植入物对持续眼部输送RNA纳米颗粒充满希望,有助于治疗慢性眼病. 释放速度取决于纳米粒子大小和植入物膜特性.
科学领域:
- 眼部药物输送是通过眼部药物输送的.
- 生物材料科学是生物材料的科学.
- 纳米技术 纳米技术
背景情况:
- RNA纳米颗粒显示出通过子结膜路径向眼部输送的潜力.
- 持续的眼部输送对于管理慢性眼病至关重要.
- 周眼水库植入物可以延长纳米粒子在眼睛中的停留时间.
研究的目的:
- 制造和描述用于眼部药物输送的表皮质水库植入物.
- 使用模型透剂和RNA纳米粒子评估植入物的体外性能.
- 评估受阻传输理论的适用性,以了解释放动力学.
主要方法:
- 储体植入物的制造.
- 在体外释放测试用光素-异硫酸 (FITC) 标记的德克斯 (10,40,150 kDa) 和RNA纳米粒子.
- 释放动力学和植入物膜透性的分析.
- 阻碍运输理论的应用.
主要成果:
- 植入物制造是成功的.
- 释放率受到透/纳米粒子大小和植入物膜特征的影响.
- 阻碍运输理论提供了对跨膜传递和眼部药理动学的见解.
- 环膜植入物显示出延长RNA纳米粒子传递的潜力.
结论:
- 环膜植入物是持续眼部输送RNA纳米颗粒的可行策略.
- 了解运输机制是优化基于纳米粒子的眼疗法的关键.
- 这种方法有可能改善慢性眼部疾病的治疗.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
130
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
130
Ophthalmic Drug Delivery Systems
245
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
245


